MERISTEM

USPTO USPTO 1997 CANCELLED - SECTION 8

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die US-Marke MERISTEM wurde als Wortmarke am 18.12.1997 beim Amerikanischen Patent- und Markenamt angemeldet.
Sie wurde am 14.11.2000 im Markenregister eingetragen. Der aktuelle Status der Marke ist "CANCELLED - SECTION 8".

Markendetails Letztes Update: 07. Mai 2018

Markenform Wortmarke
Aktenzeichen 75407884
Registernummer 2403115
Anmeldedatum 18. Dezember 1997
Veröffentlichungsdatum 28. März 2000
Eintragungsdatum 14. November 2000

Markeninhaber

8, RUE DES FRERES LUMIERE
63100 CLEMONT-FERRAND
FR

Markenvertreter

Waren und Dienstleistungen

1 [ Chemicals for use in the manufacture of photographic materials, namely, dyes, wetting agents, fixing agents, developing agents, and stabilizers; chemicals for use in the manufacture of paints, dyes, cosmetics, glues and surfactants; chemicals for use in the manufacture of horticultural materials, namely, soil conditioners, fertilizers; chemicals for use in the manufacture of hormones, peptides, enzymes, and proteins, namely, plant and animal and microbial growth hormones, growth regulators and inhibitors, diagnostic reagents, cell growth media, cell regulatory agents, amino acids, DNA fragments, RNA fragments, DNA probes, RNA probes, genetic cloning materials, genetic expression amplifiers ]
3 [ Proteins for use as ingredients in skin lotions, oils and creams; for use as ingredients in sun tan lotions, oils and creams; for use as ingredients in skin hydrating lotions, oils and creams, namely, collagen, serum albumin, RNA, DNA and their extracts, amino acids, ribosomes, ceramides, immunostimulating or immunoregulatory hormones, all obtained from plants; and enzymes for use as ingredients in skin lotions, oils and creams; for use as ingredients in sun tan lotions, oils and creams; for use as ingredients in skin hydrating lotions, oils and creams, namely, proteases, hydrolases, lipases, deshydroxylases and cellulases, all obtained from plants ]
5 [ pharmaceutical preparations for use in the treatment of cystic fibrosis, obesity, emphysema, hemoglobin insufficiency, blood oxygen insufficiency, albumin insufficiency, collagen insufficiency, auto-immune diseases, namely, human immunodeficiency virus and multiple sclerosis, iron insufficiency and rabies; veterinary preparations for the treatment of rabies, obesity, auto-immune diseases, namely, feline immunodeficiency virus and simian immunodeficiency virus, in livestock, domestic pets and wild animals, namely, foxes and rodents; acaricides, algaccides, biopesticides, herbicides, insecticides, miticides, pesticides and weed killers for agricultural, domestic or commercial use; pharmaceutical preparations produced from plants or containing proteins produced from plants, for use in the treatment of cystic fibrosis, obesity, emphysema, hemoglobin insufficiency, blood oxygen insufficiency, albumin insufficiency, collagen insufficiency, auto-immune diseases, namely, human immunodeficiency virus and multiple sclerosis, iron insufficiency and rabies; therapeutic proteins, hormones, peptides and their complexes, derivatives and cofactors, namely, human serum albumin, lactoferrin, hemoglobin, collagen and procollagen for use in the treatment of cystic fibrosis, obesity, emphysema, hemoglobin insufficiency, blood oxygen insufficiency, albumin insufficiency, collagen insufficiency, auto-immune diseases, namely, immunodeficiency virus and multiple sclerosis, iron insufficiency and rabies; vaccines including antibodies or glycoproteins, namely, glycoprotein G, lipases, namely, gastric lipase, pancreatic lipase; and medicines and pharmaceutical preparations obtained from genetically modified plants or containing the extracts of genetically modified plants for use in the treatment of cystic fibrosis, obesity, emphysema, hemoglobin insufficiency, blood oxygen insufficiency, albumin insufficiency, collagen insufficiency, auto-immune diseases, namely, immunodeficiency virus and multiple sclerosis, iron insufficiency and rabies ]
42 Scientific and industrial research, namely biotechnological research on chemical products intended for industry, science, photography, agriculture, horticulture and forestry, on proteins for pharmaceutical use or for cosmetic use, these proteins being produced from plants, on pharmaceutical and veterinary products and hygiene products coming under the pharmaceutical monopoly, on biotechnological products produced from plants; biological and biotechnological laboratory services; research and development work in plant-based biotechnology
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

ID: 1375407884